Jun 20, 2024 · Arcturus Therapeutics is a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases

Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.

In a wholly owned program, Arcturus is developing a messenger RNA (mRNA) medicine to treat ornithine transcarbamylase deficiency, a life-threatening genetic disease that affects over 10,000 people worldwide.

RNA, DNA and enzymes are rapidly degraded in the gut and in the blood stream. Arcturus’s proprietary LUNAR ® technology can be used to deliver gene editing tools directly into target cells where they can edit out disease-causing mutations.

The latest news and publications for Arcturus Therapeutics, including vaccine news, COVID-19 publications, rare disease scientific publications including Ornithine Transcarbamylase, Cystic Fibrosis, and posters.

Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics.

Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial

Dr. Pad Chivukula is the co-founder of Arcturus Therapeutics and has served as the Chief Scientific Officer and Chief Operating Officer since 2013. With a deep foundation in nanoparticle technology, Dr. Chivukula leads Arcturus in discovering and developing transformative medicines for diseases with unmet needs.

Get in touch with Arcturus Therapeutics. Visit our contact page for inquiries about our innovative RNA-based therapies.

Mar 31, 2024 · © 2025 Arcturus Therapeutics, Inc. 5. STARR ® self-replicating RNA-based prophylactic vaccine triggers rapid and prolonged antigen expression within host cells resulting …